Clinical trials
Neurological Diseases or Conditions clinical trials
Below are recruiting neurological diseases or conditions clinical trials, each written for real people, not researchers. We’re tracking 4,561 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06506058Recruiting
Study on balance and brain in Parkinson's freezing of gait
This study looks at how the balance system and brain work together to cause freezing of gait in Parkinson's disease. By understanding these factors, researchers hope to find better ways to help people walk more steadily.
Minneapolis, MinnesotaAges 21–80 - NCT06506656Recruiting
Testing Hyadrol gel for hip or thumb arthritis pain
This study tests whether a combination of hyaluronic acid and adelmidrol (a gel called Hyadrol) can reduce pain and improve joint function in people with arthritis of the hip or thumb. It may help if you have persistent pain and are not already on other treatments.
RomaAges 40 years+ - NCT06508268Recruiting
Language, speech, and movement in early Alzheimer's
This study looks at how language, speech, and motor skills change in people with mild cognitive impairment (early memory problems) due to Alzheimer's disease, and in people with Alzheimer's disease. It also includes healthy older adults for comparison. The goal is to better understand these changes, which may help with earlier diagnosis.
GroningenAges Any age - NCT06508801Recruiting
Blood flow restriction to improve balance in Parkinson's
This study tests whether gently restricting blood flow to your legs during exercise can help improve balance for people with Parkinson's disease. You will do simple leg exercises while wearing a special cuff, which may strengthen muscles and improve steadiness.
San Antonio, TexasAges 40–85 - NCT06511050RecruitingPhase 1/Phase 2
Testing Lumbrokinase for Long COVID, Lyme, and Chronic Fatigue
This trial tests a supplement called Lumbrokinase (derived from earthworms) to see if it helps reduce symptoms in people with Long COVID, post-treatment Lyme disease syndrome, or ME/CFS. It may benefit those whose daily life is significantly affected by these conditions.
New York, New YorkAges 18 years+ - NCT06512441Recruiting
Vitamin B6 for inflammatory bowel disease
This study tests whether vitamin B6 can help treat inflammatory bowel disease (IBD). It may offer a simple, low-cost option to support your current treatment.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06514001RecruitingPhase 2
Testing a new drug for Alzheimer's disease with eye scans
This trial tests an investigational drug called AMDX-2011P for people with Alzheimer's disease. It looks at whether the drug affects the retina, which may be linked to brain changes in Alzheimer's.
Phoenix, ArizonaAges 18 years+ - NCT06520137Recruiting
Wisdom tooth removal and gum disease study
This study looks at how removing an impacted upper wisdom tooth affects gum health. It may help people who need this tooth removed and do not have advanced gum disease.
Siena, Italy/SIAges 19–64 - NCT06523296Recruiting
Antibodies and thinking problems in myasthenia or Alzheimer's
This study looks at whether certain antibodies are linked to memory and thinking problems in people with myasthenia gravis or Alzheimer's disease. It involves a one-time use of leftover spinal fluid from a previous diagnostic test.
Nice, Alpes MaritimesAges 18 years+ - NCT06526195Recruiting
A study of CardioMEMS and HeartMate 3 for advanced heart failure
This trial tests if a combination of a tiny lung-artery pressure sensor (CardioMEMS) and a mechanical heart pump (HeartMate 3) is safe and effective for people with advanced heart failure. If you qualify, you'll either get the heart pump plus standard medical therapy, or continue with standard therapy alone and have your pressure monitored remotely.
Phoenix, ArizonaAges 18 years+ - NCT06528418Recruiting
Breath test to find lung diseases
This study uses a simple breath test to detect different lung diseases. By analyzing the chemicals in your breath, researchers hope to find a faster, non-invasive way to diagnose lung conditions. It may be an option if you have a known lung disease and have a recent CT scan.
Guangzhou, GuangdongAges 18–100 - NCT06530732RecruitingPhase 3
Neck drainage surgery for Alzheimer's disease
This study tests a new surgical treatment for Alzheimer's disease. The surgery aims to improve drainage in the neck to help clear waste from the brain. This is a first-of-its-kind pilot study to see if it is safe and might help thinking and memory.
Hangzhou, ZhejiangAges Any age - NCT06535308RecruitingPhase 1
Testing a new Alzheimer's drug for moderate disease
This study tests a new drug (BnH-015B) for people with moderate Alzheimer's disease. It also includes a small group of healthy young men for comparison. The goal is to see if the drug is safe and how it works in the body.
Seoul, Jongno-guAges 19–45 - NCT06536348Recruiting
Parkinson's disease database study in Brazil
This study is creating a database of motor and non-motor symptoms in people with Parkinson's disease in Brazil. It aims to better understand the condition by collecting information, and participation involves tests and questionnaires.
Brasília, Federal DistrictAges 18–120 - NCT06536478Recruiting
Exercise for posture and flexibility in Parkinson's disease
This study tests whether a special exercise program can improve your posture, flexibility, and spine health. It is designed for people with mild to moderate Parkinson's disease who are stable on their medications.
HsinchuAges 30–85 - NCT06537258Recruiting
Heart rate and stress in teens with IBD
This study tests whether a virtual program can help teens with IBD who also have depression or anxiety. It looks at how stress affects the body through heart rate patterns and aims to improve both gut and emotional health.
Atlanta, GeorgiaAges 13–18 - NCT06538298RecruitingEarly Phase 1
Exercise program with games for Parkinson's
This study tests a fun exercise program that includes games for people with Parkinson's disease. It aims to see if this type of program can help improve movement and daily life.
Ventura, CaliforniaAges 40–80 - NCT06538311RecruitingEarly Phase 1
TMS treatment for early Alzheimer's disease
This study tests whether a non-invasive brain stimulation treatment called TMS (transcranial magnetic stimulation) can help people with early Alzheimer's disease or related memory problems. It's a safe, gentle way to stimulate brain cells using magnetic pulses.
Boston, MassachusettsAges 40–99 - NCT06539624Recruiting
Testing a new gene therapy for Fabry disease
This trial is testing a new treatment called EXG110 for people with Fabry disease. It's designed to see if it's safe and if it can help. You may be able to join if you have a confirmed diagnosis and at least one symptom of Fabry disease.
Shanghai, Shanghai MunicipalityAges 7 years+ - NCT06540989RecruitingEarly Phase 1
Speech therapy with computer feedback for Parkinson's
This study tests a new speech therapy approach for people with Parkinson's disease who have mild to moderate speech problems. It uses a computer program that listens to your speech and helps you practice speaking more clearly.
New York, New YorkAges 50–80 - NCT06544434RecruitingPhase 2
Laser acupuncture for Meniere disease
This trial tests if laser acupuncture can help people with Meniere disease, a condition that causes dizziness, hearing loss, and ringing in the ears. It compares laser acupuncture to a placebo to see if it reduces symptoms.
BeijingAges 18–65 - NCT06546488Recruiting
Cognitive Testing for Huntington's Disease Study
This study tests new ways to measure thinking and memory skills in people with Huntington's disease. It aims to find better tools for tracking the disease and could help you understand your cognitive changes.
Columbus, OhioAges 30–65 - NCT06546761Recruiting
Heart imaging after carotid artery treatment
This study tests whether imaging the heart's arteries with a special CT scan can help find hidden blockages in people who just had treatment for a blocked carotid artery. It aims to prevent future heart problems.
RigaAges 50 years+ - NCT06548607RecruitingEarly Phase 1
CAR-T therapy for autoimmune diseases
This early-phase trial tests a new CAR-T cell therapy that targets CD19 or both CD19 and BCMA to treat several autoimmune diseases like lupus, scleroderma, and vasculitis. It aims to calm the overactive immune system with a single infusion of your own engineered cells.
Bengbu, AnhuiAges 18–70
Hear when a new Neurological Diseases or Conditions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neurological diseases or conditions?
- Yes. Clin2 currently lists 4,561 recruiting neurological diseases or conditions studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neurological diseases or conditions trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neurological diseases or conditions trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.